| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/22/1999 | WO1999036088A1 RECOMBINANT CtB-BASED VACCINES |
| 07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036065A1 Medicinal compositions |
| 07/22/1999 | WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | CA2318664A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | CA2318555A1 Thiophene nitrone compounds |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318498A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | CA2318493A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | CA2318402A1 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318357A1 Thioether furan nitrone compounds |
| 07/22/1999 | CA2318284A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | CA2318231A1 Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/21/1999 | EP0930310A1 Isocoumarin derivatives and use thereof in drugs |
| 07/21/1999 | EP0930075A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 07/21/1999 | EP0929684A2 Phospholipase d and dna sequences |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929549A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors |
| 07/21/1999 | EP0929533A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929517A1 Hydroxamic acid derivatives |
| 07/21/1999 | EP0929316A1 Novel product and process for t lymphocyte veto |
| 07/21/1999 | EP0929302A1 Il-8 receptor antagonists |
| 07/21/1999 | EP0929300A2 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 07/21/1999 | EP0765327B1 Pyrazolo and pyrrolopyridines |
| 07/21/1999 | CN1223586A Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/21/1999 | CN1044235C Sulfonamide endothelin antagonists |
| 07/20/1999 | US5925789 Multistage process with amination, dehydration and stirring to give an intermediate in the synthesis of 6-chloro-4-cyclo propylethynyl-4-trifluoromethyl-1,4-2h-3,1-benzoxazine-2-one as an inhibitor of hiv reverse transcriptase |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925768 Antiinflammatory agents; analgesics, anticoagulants, narcotics |
| 07/20/1999 | US5925761 Synthesis of terfenadine and derivatives |
| 07/20/1999 | US5925735 Hematopoietic cytokine receptor |
| 07/20/1999 | US5925649 Ascomycins |
| 07/20/1999 | US5925643 Treating human immunodeficiency virus infections |
| 07/20/1999 | US5925636 Inhibitors of tumor necrosis factor, phosphodiesterase |
| 07/20/1999 | US5925624 Antiinflammatory agents treating patients with inflammatory conditions susceptible to leukocyte-induced tissue damage |
| 07/20/1999 | US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient. |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925362 Method to elicit an antitumor response with human prostate-specific antigen |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/15/1999 | WO1999035277A2 Recombinant, active caspases and uses thereof |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035163A1 Phenylalanine derivatives |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999035144A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999035116A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999034830A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | WO1999034826A1 Methods and compositions for desensitisation |
| 07/15/1999 | WO1999034817A1 Agent for treating allergic or hypersensitivity condition |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999025823A3 Recombinant allergen with reduced enzymatic activity |
| 07/15/1999 | WO1999025734A3 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
| 07/15/1999 | WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998042855A9 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2318369A1 Recombinant, active caspases and uses thereof |
| 07/15/1999 | CA2317724A1 Methods and compositions for desensitisation |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2317010A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2282596A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/14/1999 | EP0928197A1 Use of proteins as agents against autoimmune diseases |
| 07/14/1999 | EP0820772A4 Immunomodulating medicinal agent |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0581856B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/14/1999 | EP0553198B1 Regulation of immunoglobulin production by interleukin-9 |
| 07/14/1999 | CN1222911A Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 07/14/1999 | CN1222385A Reverse transcriptase inhibitor |
| 07/14/1999 | CN1222352A Preparation of high-immunity pig-sourced serum resisting main infectious diseases of chicken |
| 07/14/1999 | CN1044116C Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action and use thereof |
| 07/14/1999 | CN1044092C Antigen-antibody-recombination DNA composite type vaccin |
| 07/14/1999 | CN1044089C Medicine composition with enantiomerically pure beta-D-dioxolane nucleosides as active component |
| 07/13/1999 | US5922887 Novel delta opiod modulators for the treatment or prophylaxis of pain, organ transplant rejection, diarrhea, epileptic seizures, neurological diseases, and other disorders |
| 07/13/1999 | US5922848 Purifying toxin from sample by forming complex with galactose disaccharide covalently bonded through linker arm to support, separating complex from sample, recovering eluted toxin under alkaline, non-denaturing conditions; free of glycolipids |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922760 Agent for prevention or alleviation of allergy symptoms |
| 07/13/1999 | US5922741 5-aminopyrazoles useful as tyrosine kinase inhibitors |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922711 Antiallergens, antiinflammatory agents, autoimmune diseases, shock or analgesics |